-
Vaxart, Inc. is an
American biotechnology company focused on the discovery, development, and
commercialization of oral
recombinant vaccines administered...
-
Vaxart COVID-19
vaccine is a COVID-19
vaccine candidate developed by
Vaxart. "Patent
Landscape Report COVID-19-related
vaccines and therapeutics" (PDF)...
-
August 2021.
Retrieved 13
November 2014. "
Vaxart Completes Financing to Fund
Expanding Development Portfolio".
Vaxart.
Archived from the
original on 19 January...
-
August 2020
against Vaxart in
Northern California U.S.
District Court for
alleged securities fraud, a
concern related to
Vaxart executives enriching...
- DelNS1-2019-nCoV-RBD-OPT GRAd-COV2
ImmunityBio iNCOVACC INNA-051 NDV-HXP-S
Vaxart COVID-19
vaccine Virus-like
particles ABNCoV2 LYB001 MigVax-101 VBI-2902...
- Pharmaceutical), AstraZeneca-University of Oxford, Pfizer-BioNTech, Moderna, Merck,
Vaxart, and Inovio.
Funding from
BARDA totaled more than $2
billion by the end...
-
Terrapinn Holdings.
Retrieved 21
March 2014. "Scientific
Advisory Board".
Vaxart Inc.
Retrieved 2024-11-06. "Astellas To Form
Strategic Partnership With...
- Randomized, double-blinded, placebo-controlled. July–Dec 2021,
China Vaxart COVID-19
vaccine Vaxart United States Viral vector Phase II (896) Double-Blind, Multi-Center...
- for a
number of
biotechnology companies including Day One Therapeutics,
Vaxart and WinSanTor. He also
served as CEO of Poliwogg. "Greg Simon". The Forum...
